SCHEMBL6016609

SCHEMBL6016609

COC(=O)Cc1n[nH]c2cc(N)ccc12

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.53
GSK3B P49841 6/20 0.45
MAPT P10636 2/20 0.43
AXL P30530 2/20 0.42
ALDH1A1 P00352 3/20 0.39
CYP1A2 P05177 1/20 0.39
GAA P10253 2/20 0.38
GFER P55789 1/20 0.38
CHEK1 O14757 1/20 0.37
MAP2K4 P45985 2/20 0.37
ABL1 P00519 1/20 0.37
BCR P11274 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6016427 0.89 SMN1; SMN2 (0.53) SMN1; SMN2GSK3BMAPTAXLALDH1A1
SCHEMBL14564361 0.84 SMN1; SMN2 (0.55) SMN1; SMN2GSK3BMAPTALDH1A1CYP1A2
SCHEMBL22267604 0.83 GSK3B (0.55) SMN1; SMN2GSK3BMAPTMAP2K4
SCHEMBL4300704 0.80 SMN1; SMN2 (0.71) SMN1; SMN2MAPTALDH1A1GAA
SCHEMBL6016433 0.79 SMN1; SMN2 (0.49) SMN1; SMN2GSK3BMAPTALDH1A1CYP1A2
SCHEMBL2914448 0.79 AXL (0.47) GSK3BMAPTAXLCHEK1PKM
SCHEMBL2418244 0.76 TNF (0.44) SMN1; SMN2GSK3BMAPTAXLALDH1A1
SCHEMBL15372574 0.76 GSK3B (0.44) SMN1; SMN2GSK3BMAPTAXLALDH1A1
SCHEMBL16095565 0.76 AXL (0.50) GSK3BMAPTAXLCHEK1PKM
SCHEMBL14574212 0.75 KDM4E (0.63) SMN1; SMN2GSK3BMAPTAXLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1471915-A4 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES RIGEL PHARMACEUTICALS INC (US) 2006-02-15 EP disclosed
EP-1471915-A2 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES Rigel Pharmaceuticals, Inc. (US) 2004-11-03 EP disclosed
WO-2003063794-A2 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES RIGEL PHARMACEUTICALS, INC. (US) 2003-08-07 WO disclosed